MicroRNA-203 leads to G1 phase cell cycle arrest in laryngeal carcinoma cells by directly targeting survivin

FEBS Letters

Volumn 586, Issue 6, 2012, Pages 804-809

  Bian, Ka ^a,b   Fan, Jing ^c   Zhang, Xiang ^b   Yang, Xin Wei ^c   Zhu, Hua Yu ^b   Wang, Lei ^b   Sun, Jian Yong ^b   Meng, Yan Ling ^b   Cui, Peng Cheng ^a   Cheng, Shi Yin ^a   Zhang, Jian ^b   Zhao, Jing ^b   Yang, An Gang ^b   Zhang, Rui ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cell cycle; Laryngeal carcinoma; MicroRNA; Survivin

Indexed keywords

LENTIVIRUS VECTOR; MICRORNA; MICRORNA 203; PLASMID VECTOR; SURVIVIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER GENE THERAPY; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG TARGETING; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LARYNX CARCINOMA; PRIORITY JOURNAL; QUANTITATIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CARCINOMA; CELL LINE, TUMOR; G1 PHASE CELL CYCLE CHECKPOINTS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LARYNGEAL NEOPLASMS; MICRORNAS; RNA, MESSENGER;

EID: 84862777412     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.01.050     Document Type: Article

References (38)

1. Bartel, D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
2. Lee, Y., Kim, M., Han, J., Yeom, K.H., Lee, S., Baek, S.H. and Kim, V.N. (2004) MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23, 4051-4060. (Pubitemid 39472426)
3. Lee, Y., Jeon, K., Lee, J.T., Kim, S. and Kim, V.N. (2002) MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 21, 4663-4670. (Pubitemid 34984353)
4. Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., Lee, J., Provost, P., Rådmark, O., Kim, S. and Kim, V.N. (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425, 415-419. (Pubitemid 37187272)
5. Guo, H., Ingolia, N.T., Weissman, J.S. and Bartel, D.P. (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835-8340.
6. Lim, L.P., Lau, N.C., Garrett-Engele, P., Grimson, A., Schelter, J.M., Castle, J., Bartel, D.P., Linsley, P.S. and Johnson, J.M. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433, 769-773. (Pubitemid 40292988)
7. Lewis, B.P., Shih, I.H., Jones-Rhoades, M.W., Bartel, D.P. and Burge, C.B. (2003) Prediction of mammalian microRNA targets. Cell 115, 787-798. (Pubitemid 38058492)
8. Calin, G.A. and Croce, C.M. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857-866. (Pubitemid 44629897)
9. Medina, P.P., Nolde, M. and Slack, F.J. (2010) OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467, 86-90.
10. Kota, J., Chivukula, R.R., O'Donnell, K.A., Wentzel, E.A., Montgomery, C.L., Hwang, H.W., Chang, T.C., Vivekanandan, P., Torbenson, M., Clark, K.R., Mendell, J.R. and Mendell, J.T. (2009) Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137, 1005-1017.
11. Hardisson, D. (2003) Molecular pathogenesis of head and neck squamous cell carcinoma. Eur. Arch. Otorhinolaryngol. 260, 502-508.
12. Mirisola, V., Mora, R., Esposito, A.I., Guastini, L., Tabacchiera, F., Paleari, L., Amaro, A., Angelini, G., Dellepiane, M., Pfeffer, U. and Salami, A. (2011) A prognostic multigene classifier for squamous cell carcinomas of the larynx. Cancer Lett. 307, 37-46.
13. Hui, A.B., Lenarduzzi, M., Krushel, T., Waldron, L., Pintilie, M., Shi, W., Perez-Ordonez, B., Jurisica, I., O'Sullivan, B., Waldron, J., Gullane, P., Cummings, B. and Liu, F.F. (2010) Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin. Cancer Res. 16, 1129-1139.
14. Long, X.B., Sun, G.B., Hu, S., Liang, G.T., Wang, N., Zhang, X.H., Cao, P.P., Zhen, H.T., Cui, Y.H. and Liu, Z. (2009) Let-7a microRNA functions as a potential tumor suppressor in human laryngeal cancer. Oncol. Rep. 22, 1189-1195.
15. Cai, K.M., Bao, X.L., Kong, X.H., Jinag, W., Mao, M.R., Chu, J.S., Huang, Y.J. and Zhao, X.J. (2010) Hsa-miR-34c suppresses growth and invasion of human laryngeal carcinoma cells via targeting c-Met. Int. J. Mol. Med. 25, 565-571.
16. Liu, M., Wu, H., Liu, T., Li, Y., Wang, F., Wan, H., Li, X. and Tang, H. (2009) Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma. Cell Res. 19, 828-837.
17. Furuta, M., Kozaki, K.I., Tanaka, S., Arii, S., Imoto, I. and Inazawa, J. (2010) MiR- 124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 31, 766-776.
18. Yuan, Y., Zeng, Z.Y., Liu, X.H., Gong, D.J., Tao, J., Cheng, H.Z. and Huang, S.D. (2011) MicroRNA-203 inhibits cell proliferation by repressing DNp63 expression in human esophageal squamous cell carcinoma. BMC Cancer 11, 57.
19. Bueno, M.J., Pérez de Castro, I., Gómez de Cedrón, M., Santos, J., Calin, G.A., Cigudosa, J.C., Croce, C.M., Fernández- Piqueras, J. and Malumbres, M. (2008) Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCRABL1 oncogene expression. Cancer Cell 13, 496-506.
20. Li, J., Chen, Y., Zhao, J., Kong, F. and Zhang, Y. (2011) MiR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression. Cancer Lett. 304, 52-59.
21. Bo, J., Yang, G., Huo, K., Jiang, H., Zhang, L., Liu, D. and Huang, Y. (2011) MicroRNA-203 suppresses bladder cancer development by repressing bcl-w expression. FEBS J. 278, 786-792.
22. Chiang, Y., Song, Y., Wang, Z., Chen, Y., Yue, Z., Xu, H., Xing, C. and Liu, Z. (2011) Aberrant expression of miR-203 and its clinical significance in gastric and colorectal cancers. J. Gastrointest. Surg. 15, 63-70.
23. Saini, S., Arora, S., Majid, S., Shahryari, V., Chen, Y., Deng, G., Yamamura, S., Ueno, K. and Dahiya, R. (2011) Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer. Cancer Prev. Res. (Phila.) 4, 1698-1709.
24. Saini, S., Majid, S., Yamamura, S., Tabatabai, L., Suh, S.O., Shahryari, V., Chen, Y., Deng, G., Tanaka, Y. and Dahiya, R. (2011) Regulatory role of mir-203 in prostate cancer progression and metastasis. Clin. Cancer Res. 17, 5287-5298.
25. Ikenaga, N., Ohuchida, K., Mizumoto, K., Yu, J., Kayashima, T., Sakai, H., Fujita, H., Nakata, K. and Tanaka, M. (2010) MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma. Ann. Surg. Oncol. 17, 3120-3128.
26. Zhang, R., Ma, L., Zheng, M., Ren, J., Wang, T., Meng, Y., Zhao, J., Jia, L., Yao, L., Han, H., Li, K. and Yang, A. (2010) Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice. Cancer Gene Ther. 17, 275-288.
27. Thomas, M., Lieberman, J. and Lal, A. (2010) Desperately seeking microRNA targets. Nat. Struct. Mol. Biol. 17, 1169-1174.
28. Li, F. and Altieri, D.C. (1999) The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression. Cancer Res. 59, 3143-3151. (Pubitemid 29316014)
29. Ito, T., Shiraki, K., Sugimoto, K., Yamanaka, T., Fujikawa, K., Ito, M., Takase, K., Moriyama, M., Kawano, H., Hayashida, M., Nakano, T. and Suzuki, A. (2000) Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology 31, 1080-1085. (Pubitemid 30233232)
30. Zhang, R., Wang, T., Li, K.N., Qin, W.W., Chen, R., Wang, K., Jia, L.T., Zhao, J., Wen, W.H., Meng, Y.L., Yao, L.B. and Yang, A.G. (2008) A survivin double point mutant has potent inhibitory effect on the growth of hepatocellular cancer cells. Cancer Biol. Ther. 7, 547-554. (Pubitemid 351847030)
31. Li, F. and Altieri, D.C. (1999) Transcriptional analysis of human survivin gene expression. Biochem J. 344, 305-311. (Pubitemid 30011584)
32. Zhao, J., Tenev, T., Martins, L.M., Downward, J. and Lemoine, N.R. (2000) The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycledependent manner. J. Cell Sci. 113, 4363-4371. (Pubitemid 32000697)
33. Saini, S., Yamamura, S., Majid, S., Shahryari, V., Hirata, H., Tanaka, Y. and Dahiya, R. (2011) MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. Cancer Res. 71, 6208-6219.
34. Yoon, S., Choi, Y.C., Lee, S., Jeong, Y., Yoon, J. and Baek, K. (2010) Induction of growth arrest by miR-542-3p that targets survivin. FEBS Lett. 584, 4048-4052.
35. Alajez, N.M., Lenarduzzi, M., Ito, E., Hui, A.B., Shi, W., Bruce, J., Yue, S., Huang, S.H., Xu, W., Waldron, J., O'Sullivan, B. and Liu, F.F. (2011) MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res. 71, 2381-2391.
36. Marioni, G., Ottaviano, G., Marchese-Ragona, R., Giacomelli, L., Bertolin, A., Zanon, D., Marino, F. and Staffieri, A. (2006) High nuclear expression of the apoptosis inhibitor protein survivin is associated with disease recurrence and poor prognosis in laryngeal basaloid squamous cell carcinoma. Acta Otolaryngol. 126, 197-203. (Pubitemid 43155505)
37. Dong, Y., Sui, L., Watanabe, Y., Sugimoto, K. and Tokuda, M. (2002) Survivin expression in laryngeal squamous cell carcinomas and its prognostic implications. Anticancer Res. 22, 2377-2383. (Pubitemid 34857069)
38. Xue, Q., Guo, Z.Y., Li, W., Wen, W.H., Meng, Y.L., Jia, L.T., Wang, J., Yao, L.B., Jin, B.Q., Wang, T. and Yang, A.G. (2011) Human activated CD4(+) T lymphocytes increase IL-2 expression by downregulating microRNA-181c. Mol. Immunol. 48, 592-599.